Quick Answer
ABEONA THERAPEUTICS INC. reported Diluted EPS of $1.01 per share for fiscal year 2025.
ABEONA THERAPEUTICS INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.01 | +165.2% |
| 2024 | -$1.55 | +38.7% |
| 2023 | -$2.53 | +54.2% |
| 2022 | -$5.53 | +63.8% |
| 2014 | -$15.26 | -602.0% |
| 2013 | $3.04 | +684.6% |
| 2012 | -$0.52 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.10 | +84.1% | -105.8% |
| June 30, 2025 | $1.71 | +757.7% | +812.5% |
| March 31, 2025 | -$0.24 | +79.3% | +61.9% |
| September 30, 2024 | -$0.63 | -31.3% | -142.3% |
| June 30, 2024 | -$0.26 | +71.7% | +77.6% |
| March 31, 2024 | -$1.16 | -114.8% | -141.7% |
| September 30, 2023 | -$0.48 | +52.0% | +47.8% |
| June 30, 2023 | -$0.92 | -167.6% | -70.4% |
- ABEONA THERAPEUTICS INC. showed an increase of +165.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2012–2025 period, ABEONA THERAPEUTICS INC.’s diluted eps has grown by 294.2% (from $0.52 per share (loss) to $1.01 per share).
- The most recent figure is from ABEONA THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: